NCT02134574Recruiting
Prospective Cohort With Hemopathy in Languedoc-Roussillon
Prospective Cohort Study of Clinical and Laboratory Data of Patients With Hemopathy in Languedoc-Roussillon
Source: ClinicalTrials.gov · Last updated 22 Jun 2026
Brief summary (registry, in English)
Prospective Cohort Study of clinical and laboratory data of patients with hemopathy.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 500 (estimated)
- First submitted
- 22 Apr 2014
- Start date
- Feb 2014
- Primary completion date
- Jun 2033
- Lead sponsor
- University Hospital, Montpellier
- Diseases
- Hodgkin lymphoma, Multiple myeloma
- NCT number
- NCT02134574
What you commit to
- Study type: Observational
- Planned participants: 500
- From Feb 2014 to the primary completion date, Jun 2033
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients who have received treatment for hematological pathology
Other
- Minor or major protected
Who the study is looking for
- Age over 18
- Consultant or hospitalized patient for suspected malignant hemopathy and justifying further exploration or patient with a diagnosis of malignant hemopathy less than 6 months old at the time of signing the consent
- Having signed an informed consent
- Affiliated with a social security scheme
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hematology department - UHMontpellier Saint éloi Coordinator of this site? Confirm its status | Montpellier | France | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.